ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The following consolidated financial statements of Molecular Devices and
financial statement schedules are attached to this report as pages F-1 through
F-16.
Financial Statements   - Report of Ernst & Young LLP, Independent Auditors
- Consolidated Balance Sheets at December 31, 1999 and 1998
- Consolidated Statements of Income for each of the three years in the
period ended December 31, 1999
- Consolidated Statement of Stockholders' Equity for the three years in the
period ended December 31, 1999
- Consolidated Statements of Cash Flows for each of the three years in the
period ended December 31, 1999
- Notes to Consolidated Financial Statements
Financial Statement Schedules     Schedule II -- Valuation and Qualifying Accounts
All other schedules are omitted because they are not applicable or the
required information is shown in the consolidated financial statements or notes
thereto.
Item 2.   21
Item 3. Legal   21
Item 4. Submission of Matters to a Vote of Security
21
PART II
Item 5. Market for Registrant Common Equity and Related
Stockholder   22
Item 6. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
Information with respect to Directors and Executive Officers may be found
in the sections entitled Proposal 1 -- Election of Directors, and Executive
Officers of the Company, respectively, appearing in the definitive Proxy
Statement to be delivered to stockholders in connection with the solicitation of
proxies for our Annual Meeting of Stockholders to be held on May 25, 2000 the
Proxy Statement. Such information is incorporated herein by reference.
Item 2.   21
Item 3. Legal   21
Item 4. Submission of Matters to a Vote of Security
21
PART II
Item 5. Market for Registrant Common Equity and Related
Stockholder   22
Item 6. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The information required by this item is set forth in the Proxy Statement
under the heading Security Ownership of Certain Beneficial Owners and
Management, which information is incorporated herein by reference.
